Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Study Program: Cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis-Reference-Cited by-同舟云学术

Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Study Program: Cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis

Published:2006-08 Issue:2 Volume:152 Page:237-245
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Cannon Christopher P.,Curtis Sean P.,Bolognese James A.,Laine Loren

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Gastrointestinal effects of NSAIDs and coxibs;Laine;J Pain Symptom Manage,2003

2. Serious lower gastrointestinal clinical events with nonselective NSAID or Coxib Use;Laine;Gastroenterology,2003

3. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial;Bresalier;N Engl J Med,2005

4. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention;Solomon;N Engl J Med,2005

5. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial;Farkouh;Lancet,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials;Journal of Internal Medicine;2022-05-31

2. The COX‐2 inhibitor etoricoxib reduces experimental osteoarthritis and nociception in rats: The roles of TGF‐β1 and NGF expressions in chondrocytes;European Journal of Pain;2019-10-13

3. Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac;International Journal of Rheumatology;2018-12-09

4. The use of non-steroidal anti-inflammatory drugs in neurological diseases;Journal of Chemical Neuroanatomy;2018-01

5. Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited;Postgraduate Medicine;2017-12-15